Clune & Associates »

Acumen Pharmaceuticals shares owned by Clune & Associates

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Clune & Associates from 13F filings

Historical chart of Clune & Associates investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Clune & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Clune & Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $28k 17k 1.71
2025-06-30 $19k 17k 1.16
2025-03-31 $18k 17k 1.10
2024-12-31 $28k 17k 1.72

More positions owned by Clune & Associates

Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Dimensional Etf Trust Short Duration F (DFSD)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Core 1 5 Yr Usd (ISTB)
Dimensional Etf Trust Intl Small Cap E (DFIS)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
American Centy Etf Tr Us Large Cap Vlu (AVLV)

View all positions for Clune & Associates

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
Franklin Resources
FMR
Vanguard Group
Knollwood Investment Advisory
Alyeska Investment Group
ADAR1 Capital Management
Laurion Capital Management
Pathstone Holdings
Hudson Bay Capital Management
Millennium Management
Renaissance Technologies
Citadel Advisors
Two Sigma Advisers

View all funds holding Acumen Pharmaceuticals